Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP Facebook

Carac-Kuric mix-ups

From the October 23, 2008 issue

Sanofiaventis is distributing a letter to pharmacists regarding the risk of mix-ups between its CARAC (fluorouracil) cream (0.5%), used for the topical treatment of multiple actinic or solar keratoses of the face and anterior scalp, and Altana’s KURIC (ketoconazole) cream (2%), used for the topical treatment of fungal infections and seborrheic dermatitis. The letter provides details about a dispensing error caused by an improperly transcribed verbal order for Kuric, which was misheard as Carac and dispensed to a patient. The patient developed a severe rash with erythema, irritation, peeling of the skin, and secondary infection involving the application site and surrounding areas following the dispensing error. Sanofi-aventis has suggested precautions to prevent this mix-up, including clarification of oral and written orders, verification of the brand and generic names, spelling the product name when reading back oral orders, matching the product’s indication to the patient’s condition, and drawing attention to the differences in the names of these products. To view the letter, visit: CaracLetter20080110.pdf.  


Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Newsletter Editions
Acute Care
Long Term Care
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2018 Institute for Safe Medication Practices. All rights reserved